Want to track PALI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Palisade Bio Inc. (PALI) Statistics
Valuation metrics
Market Cap 291.61M
Enterprise value 169.4M
Trailing P/E (ttm) -15.11
Forward P/E -8.77
PEG ratio -0.06
Price/Sales (ttm) -
Price/Book (mrq) 2.86
Enterprise Value/Revenue -
Enterprise Value/EBITDA -6.37
Overview
Shares outstanding 159.64M
Float 122.67M
Shares short 25.77M
% Held by insiders 0%
% Held by institutions 0.82%
Average volume (10 days) 4.31M
Average volume (90 days) 4M
Price summary
52-Week low 0.53
52-Week high 2.86
Beta 1.47
50-Day moving average 2.02
200-Day moving average 1.93
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:15
Last split Date 8 Apr 2024
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.18%
Return on equity -0.37%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -18.05M
Net income to common (ttm) -16.78M
Diluted EPS (ttm) -0.12
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 133.38M
Total cash per share (mrq) 0.63
Total debt (mrq) 71K
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 23.71%
Book value per share (mrq) 0.61
Cash Flow
Cash flow statement -10.85M
Levered free cash flow (LFCF) -5.92M
